Humana Inc. (NYSE:HUM) Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 9.1% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 681,265 shares of the insurance provider’s stock after purchasing an additional 56,983 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.57% of Humana worth $215,784,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Mendota Financial Group LLC boosted its holdings in shares of Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after purchasing an additional 27 shares during the last quarter. Capital Advisors Ltd. LLC boosted its holdings in shares of Humana by 17.0% during the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after purchasing an additional 31 shares during the last quarter. CarsonAllaria Wealth Management Ltd. boosted its holdings in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares during the last quarter. Harbour Investments Inc. boosted its holdings in shares of Humana by 10.5% during the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock worth $161,000 after purchasing an additional 41 shares during the last quarter. Finally, Baader Bank Aktiengesellschaft boosted its holdings in shares of Humana by 1.0% during the second quarter. Baader Bank Aktiengesellschaft now owns 4,421 shares of the insurance provider’s stock worth $1,649,000 after purchasing an additional 42 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of research analyst reports. UBS Group reduced their target price on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, October 4th. Jefferies Financial Group cut Humana from a “buy” rating to a “hold” rating and reduced their target price for the company from $519.00 to $253.00 in a report on Monday, October 7th. Leerink Partnrs lowered Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Cantor Fitzgerald reissued a “neutral” rating and issued a $395.00 price objective on shares of Humana in a research report on Tuesday, October 1st. Finally, Stephens reissued an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a research report on Wednesday, October 9th. One investment analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has an average rating of “Hold” and a consensus target price of $315.33.

Humana Price Performance

NYSE:HUM traded up $0.80 during midday trading on Friday, hitting $267.14. 4,660,847 shares of the stock were exchanged, compared to its average volume of 1,846,211. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The company has a market capitalization of $32.19 billion, a price-to-earnings ratio of 16.63, a P/E/G ratio of 1.91 and a beta of 0.50. The business has a 50-day moving average price of $315.89 and a two-hundred day moving average price of $338.40. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping the consensus estimate of $5.89 by $1.07. The firm had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $8.94 earnings per share. Sell-side analysts predict that Humana Inc. will post 16.06 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. Humana’s dividend payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.